By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AcelRx Pharmaceuticals 

575 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-216-3500 Fax: 650-216-6500




Company News
AcelRx (ACRX) To Hold Business Update And Second Quarter Financial Results Conference Call And Webcast On Monday, Aug. 3rd, 2015. 7/29/2015 9:10:00 AM
AcelRx (ACRX) Announces Positive CHMP Opinion For Zalviso In The Management Of Acute Moderate-To-Severe Post-Operative Pain In Adult Patients 7/24/2015 7:48:32 AM
AcelRx (ACRX) Release: Zalviso Phase 3 Orthopedic Results Published In Anesthesiology Demonstrate Significant Reductions In Post-Operative Pain 7/2/2015 7:43:40 AM
AcelRx (ACRX) To Present At Two Upcoming Investor Conferences In June 5/22/2015 6:30:55 AM
AcelRx (ACRX) Awarded Contract From Department Of Defense To Advance ARX-04 5/14/2015 6:44:36 AM
AcelRx (ACRX) Crashes as the FDA Rejects Request for Meeting on Pain Drug Device 5/4/2015 3:55:04 PM
AcelRx (ACRX) To Participate At Upcoming Investor Conferences In May 5/1/2015 9:35:48 AM
AcelRx (ACRX) To Hold First Quarter Financial Results Conference Call And Webcast On Monday, May 4th, 2015 4/30/2015 7:01:11 AM
AcelRx (ACRX) Announces Presentation Of Sublingual Sufentanil Data At The Society Of American Gastrointestinal And Endoscopic Surgeons Meeting 4/14/2015 9:41:51 AM
AcelRx (ACRX) Appoints Howard B. Rosen As Interim CEO 3/23/2015 6:33:18 AM